AR069228A1 - Compuesto del acido ciclopentil sustituido tiofen-2-carboxilico, su uso para la preparacion de un medicamento util para el tratamiento de glaucoma y composicion farmaceutica que lo comprende - Google Patents

Compuesto del acido ciclopentil sustituido tiofen-2-carboxilico, su uso para la preparacion de un medicamento util para el tratamiento de glaucoma y composicion farmaceutica que lo comprende

Info

Publication number
AR069228A1
AR069228A1 ARP080104883A AR069228A1 AR 069228 A1 AR069228 A1 AR 069228A1 AR P080104883 A ARP080104883 A AR P080104883A AR 069228 A1 AR069228 A1 AR 069228A1
Authority
AR
Argentina
Prior art keywords
glaucoma
preparation
treatment
pharmaceutical composition
cyclopentil
Prior art date
Application number
Other languages
English (en)
Spanish (es)
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40524829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR069228(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AR069228A1 publication Critical patent/AR069228A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D333/40—Thiophene-2-carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicinal Preparation (AREA)
ARP080104883 2007-11-09 2008-11-07 Compuesto del acido ciclopentil sustituido tiofen-2-carboxilico, su uso para la preparacion de un medicamento util para el tratamiento de glaucoma y composicion farmaceutica que lo comprende AR069228A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98684907P 2007-11-09 2007-11-09
US12/265,062 US9006464B2 (en) 2007-11-09 2008-11-05 Substituted cyclopentanes having prostaglandin activity

Publications (1)

Publication Number Publication Date
AR069228A1 true AR069228A1 (es) 2010-01-06

Family

ID=40524829

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080104883 AR069228A1 (es) 2007-11-09 2008-11-07 Compuesto del acido ciclopentil sustituido tiofen-2-carboxilico, su uso para la preparacion de un medicamento util para el tratamiento de glaucoma y composicion farmaceutica que lo comprende

Country Status (21)

Country Link
US (1) US9006464B2 (cg-RX-API-DMAC7.html)
EP (1) EP2217581B1 (cg-RX-API-DMAC7.html)
JP (1) JP2011503089A (cg-RX-API-DMAC7.html)
KR (1) KR20100101097A (cg-RX-API-DMAC7.html)
CN (2) CN101952261B (cg-RX-API-DMAC7.html)
AR (1) AR069228A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008324793B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0818902A2 (cg-RX-API-DMAC7.html)
CA (1) CA2705150C (cg-RX-API-DMAC7.html)
CL (1) CL2008003332A1 (cg-RX-API-DMAC7.html)
CO (1) CO6280480A2 (cg-RX-API-DMAC7.html)
DK (1) DK2217581T3 (cg-RX-API-DMAC7.html)
ES (1) ES2432058T3 (cg-RX-API-DMAC7.html)
IL (1) IL205604A (cg-RX-API-DMAC7.html)
MX (1) MX2010005105A (cg-RX-API-DMAC7.html)
NZ (1) NZ585517A (cg-RX-API-DMAC7.html)
RU (1) RU2481339C2 (cg-RX-API-DMAC7.html)
TW (1) TWI411438B (cg-RX-API-DMAC7.html)
UA (1) UA99840C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009061811A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201003304B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8673341B2 (en) 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US20100247606A1 (en) * 2009-03-25 2010-09-30 Allergan, Inc. Intraocular sustained release drug delivery systems and methods for treating ocular conditions
US20220249514A1 (en) 2019-06-28 2022-08-11 Regeus Limited Liability Company Remedy for hair growth enhancing

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7012A (en) * 1850-01-15 Improvement in mowing-machines
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives
JPS5623984B2 (cg-RX-API-DMAC7.html) * 1973-04-19 1981-06-03
US4065472A (en) * 1975-09-29 1977-12-27 Pfizer Inc. 5-(2-Carboxythiophen-5-yl)-16-aryloxy-α-tetranor-ω-tetranorprostaglandins
GB1563201A (en) * 1975-11-05 1980-03-19 Shell Int Research Preparation of herbicidally acitve alanine derivatives
US5698598A (en) * 1995-08-04 1997-12-16 Allergan EP2 -receptor agonists as agents for lowering intraocular pressure
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
AU2211700A (en) * 1998-12-24 2000-07-31 Alcon Laboratories, Inc. Prostaglandin e agonists for treatment of glaucoma
US7091231B2 (en) 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
US7585895B2 (en) * 2005-12-06 2009-09-08 Allergan, Inc. Therapeutic substituted cyclopentanes
US7427685B2 (en) * 2005-12-06 2008-09-23 Allergan, Inc. Therapeutic substituted cyclopentanes
US7439372B2 (en) * 2006-05-03 2008-10-21 Allergan, Inc. Therapeutic compounds
EP2125773B1 (en) * 2007-02-01 2011-01-26 Allergan, Inc. Thiophene derivatives useful as medicaments for treating ocular hypertension

Also Published As

Publication number Publication date
EP2217581A1 (en) 2010-08-18
NZ585517A (en) 2012-08-31
KR20100101097A (ko) 2010-09-16
CL2008003332A1 (es) 2011-08-12
AU2008324793B2 (en) 2013-12-05
RU2481339C2 (ru) 2013-05-10
CN102977048A (zh) 2013-03-20
ZA201003304B (en) 2014-03-26
IL205604A (en) 2014-06-30
IL205604A0 (en) 2010-11-30
DK2217581T3 (da) 2013-10-21
UA99840C2 (ru) 2012-10-10
AU2008324793A1 (en) 2009-05-14
TW200934500A (en) 2009-08-16
CO6280480A2 (es) 2011-05-20
EP2217581B1 (en) 2013-07-31
US20090124676A1 (en) 2009-05-14
TWI411438B (zh) 2013-10-11
CN101952261A (zh) 2011-01-19
CA2705150C (en) 2016-06-14
JP2011503089A (ja) 2011-01-27
CA2705150A1 (en) 2009-05-14
BRPI0818902A2 (pt) 2015-05-12
WO2009061811A8 (en) 2009-07-02
CN101952261B (zh) 2013-06-12
RU2010122681A (ru) 2011-12-20
MX2010005105A (es) 2010-05-27
US9006464B2 (en) 2015-04-14
WO2009061811A1 (en) 2009-05-14
ES2432058T3 (es) 2013-11-29

Similar Documents

Publication Publication Date Title
AR069228A1 (es) Compuesto del acido ciclopentil sustituido tiofen-2-carboxilico, su uso para la preparacion de un medicamento util para el tratamiento de glaucoma y composicion farmaceutica que lo comprende
AR071187A1 (es) Compuesto de arilmetil-tiazinamina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento de la enfermedad de alzheimer
AR077638A1 (es) Compuesto de (metanosulfonil -piperidin )-( alcoxi-aril) -tetrahidro- piridina , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de diabetes u obesidad
CL2007003261A1 (es) Compuestos derivados de 1,4-benzotiepina-1,1-dioxido; composicion farmaceutica; y su uso para el tratamiento de trastornos del metabolismo de lipidos, hiperlipidemia, resistencia a la insulina, diabetes y trastornos del snc, tales como esquizofrenia,
CL2007003264A1 (es) Compuestos derivados de 1,4-benzotiepina 1,1-dioxido sustituidos con radicales bencilo; producto farmaceutico; y uso para el tratamiento de trastornos del metabolismo de lipidos, hiperlipidemia, resistencia a la insulina, diabetes y trastornos del sn
BR112015019836A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112015014372A2 (pt) inibidores de autotaxina
BR112012013431A8 (pt) composto, composição farmacêutica e seu uso
MX2016015182A (es) Compuestos triciclicos antidiabeticos.
CL2012002031A1 (es) Composición farmacéutica que contiene al menos un compuesto fgf-21 (factor de crecimiento de fibroblastos 21) y al menos un agonista del glp-1r (receptor del péptido 1 similar al glucagón); y su uso para preparara un medicamento para el tratamiento de al menos un síndrome metabólico y/o aterosclerosis en un paciente.
BR112014010758A2 (pt) composições de resina reciclada e dispositivos médicos descartáveis produzidos com base em tais composições
CL2004000917A1 (es) Compuestos derivados de tiazol; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de enfermedades mediadas por 3-cinasa de dosfatidilnositol tal como enfermedades respiratorias, alergias, artritis reumatoide, osteoa
BRPI0821235A2 (pt) Composição de moldagem termoplástica, usos de composto e de composição de moldagem termoplástica, e, fibra, folha, ou uma moldagem.
SV2008003088A (es) Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen
AR053162A1 (es) Compuesto 5 - oxo - pirrolidin sustituido, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento del glaucoma.
AR060609A1 (es) Compuestos inhibidores de proteinquinasas c-fms.
AR063747A1 (es) Definilazetidinona sustituida con acido piperazina-1-sulfonico y que tiene propiedades farmacologicas mejoradas
CL2007001784A1 (es) Compuestos derivados de benzoxazol de formula la, su composicion farmaceutica, metodo para medir in vivo depositos de amoloide empleando dicha composicion, y uso del compuesto la para preparar un medicamento, y compuesto de formula ib, y su uso como precursor en la preparacion de un compuesto marcado.
BR112013005622A2 (pt) heteroaril metil amidas
UY37090A (es) Moléculas que tienen utilidad pesticida, y los productos intermediarios, las composiciones y sus procesos, relacionados
BR112012003464B8 (pt) compostos de piranil aril metil benzoquinaozlinona, uso dos mesmos, e, composição farmacêutica
CO6382089A2 (es) Compuestos,composiciones y metodos para el tratamiento de enfermadades causadas por un b-amiloide y sinucleinopatias
UY29079A1 (es) Acidos fenoxiacéticos sustituidos, composiciones que los contienen, procedimientos de preparación y aplicaciones
ECSP11010811A (es) Uso de dronedarona para la preparación de un medicamento para la prevención de ictus o ataque isquémico transitorio
CL2017000293A1 (es) Compuestos derivados de benzofurano sustituido en posición 6 por un radical que contiene boro; composición farmacéutica que los comprende; uso en el tratamiento de la hepatitis c (divisional del cl 393-2014)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal